DBV Technologies - Information regarding the total number of voting rights and total number of shares of the Company as of March 31, 2024
(Article 223-16 of the General Regulations of the Autorité des Marchés Financiers)
Market : NYSE Euronext Paris
ISIN Code: FR 0010417345
| Date | Total number of shares | Total number of voting rights |
| 03/31/2024 | 96,434,369 | Total gross of voting rights: 96,434,369 |
| Total net* of voting rights: 96,171,725 |
* Net total = total number of voting rights attached to shares – shares without voting rights
| Last Trade: | US$12.91 |
| Daily Volume: | 0 |
| Market Cap: | US$463.930M |
November 11, 2025 October 28, 2025 October 06, 2025 | |
Compass Therapeutics is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth...
CLICK TO LEARN MORE
Amneal Pharmaceuticals is a fully-integrated essential medicines company. We make healthy possible through the development, manufacturing, and distribution of generic and specialty pharmaceuticals. The Company has a diverse portfolio of over 250 products in its Generics segment and is expanding across...
CLICK TO LEARN MORE
